FERRATUM OYJ : Managers' Transactions Ferratum Oyj -

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
482
FERRATUM OYJ : Managers' Transactions

Ferratum Oyj - Managers' Transactions
____________________________________________

Person subject to the notification requirement
Name: van Groos, Pieter
Position: Member of the Board/Deputy member
Issuer: Ferratum Oyj
LEI: 74370078YLPFWHE33716

Notification type: INITIAL NOTIFICATION
Reference number: 74370078YLPFWHE33716_20180614193537_2
____________________________________________

Transaction date: 14.6.2018
Venue: XETRA - REGULIERTER MARKT (XETA)
Instrument type: SHARE
ISIN: FI4000106299
Nature of the transaction: ACQUISITION

Transaction Details
(1): Volume: 5000 Unit price: 20.00000 EUR
(2): Volume: 10053.15 Unit price: 20.10630 EUR
(3): Volume: 2025   Unit price: 20.10000 EUR

Aggregated transactions
(1): Volume: 20078.15 Volume weighted average price: 20.07815 EUR

About Ferratum Group: 

Ferratum Group is an international provider of mobile banking and digital consumer and small business loans, distributed and managed by mobile devices. Founded in 2005 and headquartered in Helsinki, Finland, Ferratum has expanded rapidly to operate in 25 countries across Europe, Africa, South and North America and the Asia-Pacific region.

As a pioneer in digital and mobile financial services technology, Ferratum is at the forefront of the digital banking revolution. Ferratum's mobile bank, launched in 2016, is an innovative mobile banking platform offering a range of banking services, including real time digital payments and transfers, within a single app. It is currently available in five European markets.  Led by its founder, Jorma Jokela, Ferratum has approximately 1.9 million active and former customers who have an account or have been granted one or more loans in the past (as at 31 December 2017), of which over 780,000 customers have an open Mobile Bank account or an active loan balance in the last 12 months.

 

Contacts:

Ferratum Group  

Dr. Clemens Krause, CFO  

T: +49 30 88715308

F: +49 30 88715309

E: clemens.krause@ferratum.com

 

 Ferratum Group

 Paul Wasastjerna

 Head of Investor Relations

 T: +358 40 7248247

 F: +358 20 741 1614

 E: paul.wasastjerna@ferratum.com

 

Smithfield, A Daniel J Edelman Company

 Alex Simmons | Brett Jacobs

 T: +44 20 3047 2543 | +44 20 3047 2537

 E: asimmons@smithfieldgroup.com

 E: bjacobs@smithfieldgroup.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Ameripath USA Collaborates with Recovery Resolutions to Support Recovery Housing

Updated Category News Views 308

Ameripath USA's New Partnership for Recovery Housing Ameripath USA has formed a strategic partnership with Recovery Resolutions LLC to significantly improve access to high-quality Addiction Recovery Homes throughout the country. This collaboration merges Ameripath's extensive real estate expertise with Recovery Resolutions' impressive success model, boasting a 95% success...

Continue Reading
Finzly’s ISO 20022 Migration Readiness Sets Industry Standards

Updated Category News Views 311

Finzly’s Innovations in ISO 20022 Payment Standards Finzly is at the forefront of transforming how financial institutions manage payments through its state-of-the-art platform designed for modern banking needs. As the shift to SWIFT MX ISO 20022 continues, Finzly's clientele is emerging as early adopters, demonstrating a commitment to embracing new technologies that...

Continue Reading
Innovative Drug Delivery Solutions for Parkinson's Disease

Updated Category News Views 251

Serina Therapeutics' Approach to Parkinson's Disease Serina Therapeutics is at the forefront of developing new treatments for complex neurological disorders, particularly Parkinson’s disease. This progressive neurological disorder significantly impacts motor functions and quality of life for those affected. With innovative solutions on the horizon, Serina is prepared to...

Continue Reading
Waters Corporation Leader to Speak at HealthCONx Conference

Updated Category News Views 124

Waters Corporation to Participate in HealthCONx Conference Waters Corporation (NYSE: WAT), located in Milford, Massachusetts, is pleased to announce its participation in the upcoming HealthCONx Conference. Udit Batra, the President and Chief Executive Officer of Waters, will engage in an insightful fireside chat set for Wednesday, December 4th, 2024, at 10:00 AM Eastern...

Continue Reading
mRNA Synthesis and Manufacturing Market Expected to Grow Steadily

Updated Category News Views 33

Growing Insights into the mRNA Synthesis and Manufacturing Market The mRNA synthesis and manufacturing market is on a promising trajectory, with projections indicating substantial growth from USD 624.4 million to USD 738.3 million by 2029. This expansion translates into a compound annual growth rate (CAGR) of 3.4%. Several factors are propelling this growth, including an...

Continue Reading